| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.093 | 0.002 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.005 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.006 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.006 |